Understanding aneuploidy tolerance mechanisms more widely, and the BCL9L/caspase-2/BID axis specifically, may unravel potential vulnerabilities in aneuploid cancers, which could be exploited to limit intercellular heterogeneity, a substrate for selection and tumor evolution. The gene discussed is CASP2; the disease is neoplasm.